Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

Rabbit anti-Arabidopsis thaliana (Mouse-ear cress) PYL11 Polyclonal Antibody
SKU: MBS9006887|Size: Inquire

PYL11 Antibody
SKU: GTR17958256|Size: 2 mg

LK-2
SKU: ABC-TC0587|Size: 1 Vial

SequaGel MD Monomer Solution
SKU: EC-845|Size: 200 mL

West Nile Virus - Envelope protein
SKU: REC31614-100|Size: 1 Each

Yellow Fever Virus- NS1
SKU: YFV-NS1-100|Size: 1 Each

Dengue Virus Serotype 4 NS1 Protein (HEK293)
SKU: DENV4-NS1-100|Size: 1 Each

West Nile Virus -NS1
SKU: WNV-NS1-100|Size: 1 Each

Tick-Borne Encephalitis Virus NS1
SKU: TBEV-NS1-100|Size: 1 Each

Glucose M9Y
SKU: 0108|Size: 500 g

Canine Anti Granulocyte Colony Stimulating Factor Antibody
SKU: GTR10434816|Size: 96 Well

Canine anti-Bullous Pemphigoid 230 antibody
SKU: MBS7277633-01|Size: 48 Well

Canine Anti Granulocyte Colony Stimulating Factor Antibody
SKU: MBS7277656-01|Size: 48 Well

Anti-VP2 (Canine parvovirus)
SKU: IT-015-012EM1-01|Size: 0.1 mg

Anti-NT-proBNP, canine
SKU: GTR18245956-01|Size: 1 mg

Anti-NT-proBNP, canine
SKU: GTR18245959-01|Size: 1 mg

Anti-CRP, canine
SKU: GTR18245964-01|Size: 1 mg

Anti-CRP, canine
SKU: GTR18245965-01|Size: 1 mg

Izenivetmab Biosimilar - Anti-NGFB (Canine) mAb - Research Grade
SKU: PX-TA1854-01|Size: 50 µg

Cirevetmab Biosimilar - Anti-TGFB1 (Canine) mAb - Research Grade
SKU: PX-TA1826-01|Size: 50 µg
